Skip to results
Modify your search
NARROW
1-15 of 15
Authors: Yoshihiro Oka
Journal Article
Temperature dependence of spray pyrolysis deposited NiOx layer in inverted perovskite solar cells Open Access
Oxford Open Energy, Volume 3, 2024, oiae003, https://doi.org/10.1093/ooenergy/oiae003
Published: 23 February 2024
Journal Article
10243-IMT-3 LONG-TERM OUTCOME OF A COCKTAIL WILMS' TUMOR 1 (WT1) VACCINATION USING TWO HLA CLASS I PEPTIDES AND ONE CLASS II PEPTIDE AGAINST RECURRENT MALIGNANT GLIOMAS Open Access
Neuro-Oncology Advances, Volume 5, Issue Supplement_5, December 2023, Page v23, https://doi.org/10.1093/noajnl/vdad141.092
Published: 10 December 2023
Journal Article
Distinct difference in tumor-infiltrating immune cells between Wilms’ tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies Open Access
Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab091, https://doi.org/10.1093/noajnl/vdab091
Published: 29 June 2021
Journal Article
IMT-07 CLINICAL TRIAL OF A COCKTAIL WILMS’ TUMOR 1 (WT1) VACCINATION USING TWO HLA CLASS I PEPTIDES AND ONE CLASS II PEPTIDE FOR RECURRENT MALIGNANT GLIOMAS Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_2, December 2019, Page ii18, https://doi.org/10.1093/noajnl/vdz039.080
Published: 16 December 2019
Journal Article
IMCT-09WT1 PEPTIDE VACCINATION FOR GLIOMAS; SURVIVALS, BIOMARKERS AND RESPONSE ASSESSMENT Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v109, https://doi.org/10.1093/neuonc/nov218.09
Published: 09 November 2015
Journal Article
IT-12WT1 PEPTIDE VACCINATION AGAINST GLIOMAS; COMBINATION WITH TEMOZOLOMIDE, BIOMARKERS AND IMMUNOLOGICAL RESPONSE Get access
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v112, https://doi.org/10.1093/neuonc/nou258.10
Published: 01 November 2014
Journal Article
WT1 PEPTIDE VACCINATION FOR MALIGNANT GLIOMAS AS A PART OF MULTI-MODAL THERAPY Get access
Neuro-Oncology, Volume 16, Issue suppl_3, July 2014, Page iii39, https://doi.org/10.1093/neuonc/nou208.60
Published: 01 July 2014
Journal Article
Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab Get access
Modern Rheumatology, Volume 21, Issue 4, 1 August 2011, Pages 420–422, https://doi.org/10.3109/s10165-010-0411-6
Published: 01 August 2011
Journal Article
Effects of Concomitant Temozolomide and Radiation Therapies on WT1-specific T-cells in Malignant Glioma Get access
Japanese Journal of Clinical Oncology, Volume 40, Issue 5, May 2010, Pages 395–403, https://doi.org/10.1093/jjco/hyp196
Published: 02 April 2010
Journal Article
Potentiometric and Calorimetric Studies on the Formation of Ethylenediamine Complexes of Copper(II) Ion in Water and Aqueous Dioxane Solutions Get access
Bulletin of the Chemical Society of Japan, Volume 57, Issue 2, February 1984, Pages 391–394, https://doi.org/10.1246/bcsj.57.391
Published: 27 June 2006
Journal Article
Potentiometric and Calorimetric Studies on the Formation of Ethylenediamine Complexes of Nickel(II) Ion in Water and Dioxane–Water Mixtures Get access
Bulletin of the Chemical Society of Japan, Volume 56, Issue 8, August 1983, Pages 2426–2431, https://doi.org/10.1246/bcsj.56.2426
Published: 27 June 2006
Journal Article
A Phase I/II Trial of a WT1 (Wilms' Tumor Gene) Peptide Vaccine in Patients with Solid Malignancy: Safety Assessment Based on the Phase I Data Get access
Japanese Journal of Clinical Oncology, Volume 36, Issue 4, April 2006, Pages 231–236, https://doi.org/10.1093/jjco/hyl005
Published: 12 April 2006
Journal Article
Absence of Mutations in the Wilms’ Tumor Gene WT1 in Primary Breast Cancer Get access
Japanese Journal of Clinical Oncology, Volume 34, Issue 2, February 2004, Pages 74–77, https://doi.org/10.1093/jjco/hyh012
Published: 01 February 2004
Journal Article
Cancer Immunotherapy Targeting Wilms’ Tumor Gene WT1 Product Get access
The Journal of Immunology, Volume 164, Issue 4, February 2000, Pages 1873–1880, https://doi.org/10.4049/jimmunol.164.4.1873
Published: 15 February 2000
Journal Article
Pre-B cells adhere to fibronectin via interactions of integrin α5/αv with RGDS as well as of integrin α4 with two distinct V region sequences at its different binding sites Get access
International Immunology, Volume 6, Issue 1, January 1994, Pages 139–147, https://doi.org/10.1093/intimm/6.1.139
Published: 01 January 1994
